![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 471/04 | |
A61K 31/506 | |||
A61K 31/53 | |||
A61P 29/00 | |||
C07D 495/10 | |||
A61K 31/517 | |||
A61P 25/00 | |||
A61P 37/00 |
(11) | Number of the document | 1973911 |
(13) | Kind of document | T |
(96) | European patent application number | 07718337.4 |
Date of filing the European patent application | 2007-01-17 | |
(97) | Date of publication of the European application | 2008-10-01 |
(45) | Date of publication and mention of the grant of the patent | 2016-01-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/001225 |
Date | 2007-01-17 |
(87) | Number | WO 2007/084557 |
Date | 2007-07-26 |
(30) | Number | Date | Country code |
759367 P | 2006-01-17 | US | |
842471 P | 2006-09-06 | US |
(72) |
FARMER, Luc, CA
MARTINEZ-BOTELLA, Gabriel, US
PIERCE, Albert, US
SALITURO, Francesco, US
WANG, Jian, US
WANNAMAKER, Marion, US
WANG, Tiansheng, US
|
(73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
(54) | AZAINDOLES USEFUL FOR THE TREATMENT OF (INTER ALIA) PROLIFERATIVE, CARDIAC, NEURODEGENERATIVE, AUTOIMMUNE OR INFLAMMATORY DISORDERS |
AZAINDOLES USEFUL FOR THE TREATMENT OF (INTER ALIA) PROLIFERATIVE, CARDIAC, NEURODEGENERATIVE, AUTOIMMUNE OR INFLAMMATORY DISORDERS |